WallStreetZenWallStreetZen

NASDAQ: ACET
Adicet Bio Inc Stock Forecast, Predictions & Price Target

Analyst price target for ACET

Based on 3 analysts offering 12 month price targets for Adicet Bio Inc.
Min Forecast
$5.00+176.24%
Avg Forecast
$11.33+526.13%
Max Forecast
$19.00+949.72%

Should I buy or sell ACET stock?

Based on 3 analysts offering ratings for Adicet Bio Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ACET stock forecasts and price targets.

ACET stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-04-23
lockedlocked$00.00+00.00%2024-04-02
lockedlocked$00.00+00.00%2024-03-20

1 of 1

Forecast return on equity

Is ACET forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
35.16%

Forecast return on assets

Is ACET forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

ACET revenue forecast

What is ACET's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$25.0M
Avg 2 year Forecast
$25.0M
Avg 3 year Forecast
$25.0M

ACET vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ACET$1.81$11.33+526.13%Strong Buy
RGLS$2.27$7.25+219.38%Buy
IMAB$1.81$8.00+341.99%Strong Buy
ANVS$13.60$25.00+83.82%Buy
GOSS$0.67$8.60+1,183.58%Strong Buy

Adicet Bio Stock Forecast FAQ

Is Adicet Bio Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ACET) stock is to Strong Buy ACET stock.

Out of 3 analysts, 1 (33.33%) are recommending ACET as a Strong Buy, 2 (66.67%) are recommending ACET as a Buy, 0 (0%) are recommending ACET as a Hold, 0 (0%) are recommending ACET as a Sell, and 0 (0%) are recommending ACET as a Strong Sell.

If you're new to stock investing, here's how to buy Adicet Bio stock.

What is ACET's revenue growth forecast for 2024-2026?

(NASDAQ: ACET) Adicet Bio's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.04%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.92%.

Adicet Bio's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast ACET's revenue for 2024 to be $2,053,849,600, with the lowest ACET revenue forecast at $2,053,849,600, and the highest ACET revenue forecast at $2,053,849,600. On average, 1 Wall Street analysts forecast ACET's revenue for 2025 to be $2,053,849,600, with the lowest ACET revenue forecast at $2,053,849,600, and the highest ACET revenue forecast at $2,053,849,600.

In 2026, ACET is forecast to generate $2,053,849,600 in revenue, with the lowest revenue forecast at $2,053,849,600 and the highest revenue forecast at $2,053,849,600.

What is ACET's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: ACET) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is ACET's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ACET price target, the average ACET price target is $11.33, with the highest ACET stock price forecast at $19.00 and the lowest ACET stock price forecast at $5.00.

On average, Wall Street analysts predict that Adicet Bio's share price could reach $11.33 by Apr 23, 2025. The average Adicet Bio stock price prediction forecasts a potential upside of 526.13% from the current ACET share price of $1.81.

What is ACET's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: ACET) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.